Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-11-15 Doerfler Douglas President and CEO Sale −123,263 $12.16 $1.5M 333,197
2021-11-15 Doerfler Douglas President and CEO Exercise or conversion · Employee Stock Option (right to buy) −123,263 519,970
2021-11-12 Masoud Maher EVP and General Counsel Exercise or conversion +25,722 $2.08 $54K 25,722
2021-11-12 Masoud Maher EVP and General Counsel Sale −25,722 $12.66 $326K 0
2021-11-12 Masoud Maher EVP and General Counsel Exercise or conversion · Employee Stock Option (right to buy) −25,722 99,278
2021-11-12 Murphy Amanda Louise Chief Financial Officer Exercise or conversion +51,103 $4.42 $226K 51,103
2021-11-12 Murphy Amanda Louise Chief Financial Officer Sale −51,103 $12.66 $647K 0
2021-11-12 Murphy Amanda Louise Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −51,103 1,098,897
2021-11-12 Ross Thomas M. EVP, Global Sales Exercise or conversion +42,590 $0.84 $36K 42,590
2021-11-12 Ross Thomas M. EVP, Global Sales Sale −42,590 $12.66 $539K 0
2021-11-12 Ross Thomas M. EVP, Global Sales Exercise or conversion · Employee Stock Option (right to buy) −42,590 139,515
2021-11-12 Holtz Ron SVP and CAO Exercise or conversion +21,485 $0.04 $859 171,736
2021-11-12 Holtz Ron SVP and CAO Sale −46,485 $12.65 $588K 125,251
2021-11-12 Holtz Ron SVP and CAO Exercise or conversion · Employee Stock Option (right to buy) −21,485 233,807
2021-11-12 Doerfler Douglas President and CEO Exercise or conversion +1,847 $0.04 $74 435,044
2021-11-12 Doerfler Douglas President and CEO Sale −101,847 $12.66 $1.3M 333,197
2021-11-12 Doerfler Douglas President and CEO Exercise or conversion · Employee Stock Option (right to buy) −1,847 643,233
2021-08-09 THOMPSON J STARK PHD Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Ross Thomas M. EVP, Global Sales Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Murphy Amanda Louise Chief Financial Officer Grant or award · Stock Option (right to buy) +10,000 10,000

Page 20 of 21 · 411 trades